Brandi Martinez
Psychiatric/Mental Health · Cincinnati, OHNPI 1679929111
Payments from drug & device makers
Across 228 payments — averaging $18.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$819
- Johnson & Johnson$815
- AbbVie$733
- Otsuka America Pharmaceutical, Inc.$435
- Alkermes, Inc.$377
- Sunovion Pharmaceuticals Inc.$305
- plus $787 from 9 others
What the payments were for
- Food & beverage$4,265100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 42 | $819 |
| Johnson & Johnson | 28 | $815 |
| AbbVie | 74 | $733 |
| Otsuka America Pharmaceutical, Inc. | 18 | $435 |
| Alkermes, Inc. | 18 | $377 |
| Sunovion Pharmaceuticals Inc. | 18 | $305 |
| E.r. Squibb & Sons, L.L.C. | 6 | $286 |
| Lundbeck LLC | 10 | $164 |
| Braeburn Inc. | 1 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $68 |
| Indivior Inc. | 3 | $43 |
| Teva Pharmaceuticals USA, Inc. | 3 | $41 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,271 in reported general payments places this provider in the 85th percentile of 1,808 psychiatric/mental health providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 38 | $4,204 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 29 | $2,844 |
| Asenapine Maleate | 11 | $2,076 |
| Divalproex Sodium ErDivalproex Sodium | 17 | $852 |
| Quetiapine Fumarate | 62 | $581 |
| Buspirone Hcl | 27 | $576 |
| Olanzapine | 24 | $571 |
| Duloxetine Hcl | 51 | $550 |
| Divalproex Sodium | 31 | $534 |
| Bupropion XlBupropion Hcl | 23 | $471 |
| Topiramate | 40 | $215 |
| Venlafaxine Hcl | 13 | $198 |
| Trazodone Hcl | 34 | $186 |
| Diazepam | 21 | $164 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 13 | $113 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Cincinnati
- Terri PopovitzCincinnati$161K
- Michelle McBrideCincinnati$29K
- Seth FramptonCincinnati$10K
- Crystal TravisJackson$333K
- Kristina RoweIronton$253K
- Patricia SparksPortsmouth$210K
- Mary HallWarren$195K
- Kassandra KornbauCanfield$170K
- Steven MatesDayton$121K
- Robert ParsonsYoungstown$119K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.